Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-17

Clinical Trial Update: Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial comparing recurrence rates of Helicobacter pylori eradication between esomeprazole and lansoprazole in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)
  • Lansoprazole (Lansoprazole)

Snippet

Sponsor: Finni Kollins | Conditions: Helicobacter Pylori Infection | Phase 2, Phase 3 | Status: COMPLETED